In September 2024, an Operational Agreement was signed between the National Research Council (CNR), as the leading institution of ELIXIR-IT, and Scientifica Venture Capital, an investment holding company focused on high-tech projects and start-ups. The agreement aims to accelerate technology transfer initiatives in the field of Big Data for Life Sciences.
The primary goal of the Agreement is to open new investment opportunities and support innovative start-ups in the life sciences sector, through the synergy between the scientific expertise and know-how provided by ELIXIR-IT and the experience of Scientifica Venture Capital in technological investments.
Thanks to the Scientifica Lab Approved network, consisting of 70 advanced facilities, Scientifica Venture Capital is able to bridge the gap between research and industry, offering to start-ups not only financial support but also access to cutting-edge laboratories and equipment.
On the other hand, ELIXIR-IT provides its scientific expertise and advanced resources for the production and computational analysis of omics data, fostering the valorization of scientific discoveries and the development of concrete industrial solutions.
The collaboration with Scientifica Venture Capital is an opportunity to make the most of these resources, promoting the growth of start-ups capable of transforming scientific innovations into tangible industrial solutions.
Together, CNR and Scientifica Venture Capital aim to strengthen and expand Italy’s open-innovation ecosystem,fostering a dynamic ecosystem where science and technology converge to drive future innovation.
“This partnership exemplifies how services developed and offered by research infrastructures can create significant synergies with business, driving innovation for the scientific and technological progress of our country,” said Prof. Graziano Pesole, head of the Italian node of ELIXIR.
